Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2021-02-14 2020-12-03
Drug Identification Number 02496410 02496410
Brand name TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
Common or Proper name LOTRIMAZOLE/BETAMETHASONE DIPROPIONATE LOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients BETAMETHASONE CLOTRIMAZOLE BETAMETHASONE CLOTRIMAZOLE
Strength(s) 0.05% 1% 0.05% 1%
Dosage form(s) CREAM CREAM
Route of administration TOPICAL TOPICAL
Packaging size 50 50
ATC code D01AC D01AC
ATC description ANTIFUNGALS FOR TOPICAL USE ANTIFUNGALS FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-25 2020-11-25
Estimated end date 2021-02-19 2021-01-15
Actual end date 2021-02-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments